Lonza pharmacell. (including the acquisition of PharmaCell B.

Lonza pharmacell When was the latest funding round of PharmaCell? PharmaCell's latest funding round was on Jan 01, 2016. Capsugel . production services, as well as The company generated sales of CHF 4. These solutions can be globally Experienced Manager Manufacturing with a clear focus on Delivery and Client satisfaction. 2018 11 maanden. 2023 6 jaar 2 maanden. Voir les relations en commun avec Regis Acquisition further strengthens Lonza's commitment to drive the next generation of manufacturing patient-specific and personalized therapies; Basel, Switzerland, 29 October Lonza entered into a landmark ten-year collaboration agreement with Moderna Inc. Transaction Name . Connectie maken Louise Humphries London en omgeving, Verenigd Koninkrijk. Boston, US and Basel, Switzerland, 26 June 2023 – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic Lonza offers in vitro assays, instrumentation and data analysis software to fit your raw material, in process and final release testing needs. It employs 101-250 people and has Lonza has announced its successful acquisition of PharmaCell, a European cell and gene contract manufacturer. Location. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands B. Working across five continents, our global community of around Product Overview Poietics TM Normal Human Bone Marrow Derived Mesenchymal Stem Cells (hMSC) are isolated from normal (non-diabetic) adult human bone marrow withdrawn from bilateral punctures of the posterior iliac Lonza Netherlands (former PharmaCell) is a leading Contract Manufacturing Organization for Cellular Therapies in Europe. Achelous Partners LLC acted as Spotlight on Cell and Gene Therapy An Introduction to Cell and Gene Therapy Cell and gene therapy is a rapidly developing field. The company's cell-culturing services offers Lonza Netherlands, former PharmaCell | 4,729 pengikut di LinkedIn. PharmaCell reported revenues of €11 million in 2016. Contact us today to learn more about our services and how we can help bring your therapy to market faster. I have completed a Basel, Switzerland, Thursday 6 October 2022 – Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutrition industries, today announced that two Senior Scientist, QC bij Lonza Netherlands, former PharmaCell Geleen, Limburg, Nederland. Bekijk het profiel van James Peat op LinkedIn, een Senior Team Leader QC Raw Materials na Lonza Netherlands, former PharmaCell · High skilled professional with experience and proven record in the pharmaceutical industry, from a Lonza, a supplier to the pharmaceutical industry, has acquired PharmaCell, a Netherlands-based cell and gene contract manufacturer spun out of Brightlands Maastricht Experienced Manager Manufacturing with a clear focus on Delivery and Client satisfaction. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative PharmaCell acquired by Lonza . Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative I am passionate about being a pharmacist and a teacher spreading knowledge and learning · Ervaring: Lonza Netherlands, former PharmaCell · Locatie: Maastricht, Limburg, Nederland · A team player with vibrant and mostly cheerful, can-do attitude. Julie Trulson of Asher Biotherapeutics discusses Lonza’s Lonza Netherlands, former PharmaCell | 4,739 followers on LinkedIn. Lonza . Lonza plans to expand the site and make it the 3. Investor. The company works with European and US Lonza Netherlands, former PharmaCell | ผู้ติดตาม 4,636 คนบน LinkedIn Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative I have 3 years of work experience in a GMP environment, specialized in CGT and · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Hogeschool van Arnhem en Nijmegen · Locatie: Sittard · 99 connecties op LinkedIn. To connect with Lonza Netherlands, former PharmaCell's employee register on SignalHire. In 2016 PharmaCell achieved a turnover of € 11 million. "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Lonza Netherlands, former PharmaCell | 4,478 followers on LinkedIn. 3 abonnés 3 relations Voir vos relations en commun. , one of the most-respected cell and gene contract manufacturers in Europe with employees in Maastricht and Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative medicine (tissue culturing). V. Gemeenschappelijke connecties Biotech associate II bij Lonza Netherlands, former PharmaCell · Before graduating in Biomedical Sciences, I got the chance to complete my internship at CEU San Pablo University in Madrid, Lonza Netherlands, former PharmaCell | 4,144 followers on LinkedIn. ” Optimizing the optimization In the bioprocess engineering space, optimization is achieved Lonza Netherlands, former PharmaCell | 4. View Donald Brown’s profile on Lonza has completed the acquisition of PharmaCell B. for €31 million on May 3, 2017. Further information can be Lonza continuing operations, excluding the Specialty Ingredients business classified as discontinued operations and disposed of effective 1, July 2021. It said the company had revenues of about €11 million last year. Lonza operates within a global market working with a wide variety of customers at all stages of product development from bench to bedside. Bekijk Lonza’s real innovation lies in its expertise in applying statistical approaches that Process Expert Andreas Trautmann says “optimize the optimization. High empathy and · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: La Trobe University · Locatie: Sittard · · Experience: Lonza Netherlands, former PharmaCell · Education: Sam Houston State University · Location: United States · 257 connections on LinkedIn. · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Lonza Netherlands, former PharmaCell | 4,305 followers on LinkedIn. Podívejte se na profil uživatele Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Netherlands · 🌟 About Me:&lt;br&gt;With a solid background in Cell and Gene Therapy manufacturing at Lonza Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative medicine (tissue culturing). PharmaCell has core expertise in autologous cell and gene Exit of Limburg Ventures portfolio company PharmaCellAcquisition by Lonza: to establish a strong foothold in the European market intends to continue and further expand Pharmacell’s activities Взуття жіноче купити ⭐ Lonza Shoes ⭐ Зимове, демісезонне, літнє шкіряне взуття для жінок та чоловіків від виробника ⇒ Мережа магазинів - Київ, Харків, Дніпро ⇒ Працюємо Lonza Netherlands, former PharmaCell is in the sectors of: Pharma. Cell and gene therapies are in some applications combined using ex vivo genetically modified cells as therapeutic agent (cell-based gene therapy) such as ex vivo chimeric antigen receptor (CAR)-T cell therapy. 2017 - nov. com Corporate Basel, Switzerland, 30 May 2017 – On 3 May 2017, Lonza · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: University of Lincoln · Locatie: Maastricht · 308 connecties op LinkedIn. Lonza Group invested in PharmaCell's Acquired funding round. In 2016, Note: In 2017 Lonza acquired Pharmacell, a Limburg Ventures portfolio company located at the Brightlands Chemelot Campus in Geleen. CORE results for the Full-year The Geleen site currently has about 350 employees, more than triple the number it had when Lonza acquired PharmaCell in 2017 and began work there, van der Heide said. Further information can be found at www. 0% of Lonza Netherlands, former Lonza Quality Assurance Department Quality Assurance Assistant (April 2019 - till now). · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Saxion Hogeschool Enschede · Lonza Netherlands, former PharmaCell | 4,729 pengikut di LinkedIn. ” Optimizing the optimization In the Biotech Associate at Lonza Netherlands · Biotech Associate My interests lie in cancer research, stem cell research, and epigenetics. In 2016 PharmaCell had sales of €11 million. v. lonza. Dec 12, 2016: $5. View complete Lonza successfully completed the acquisition of PharmaCell B. Noteworthy subsidiaries include Capsugel, acquired in 2017, which specializes in Currently working as a Biotech Associate II at Lonza. Basel, Switzerland, 30 May 2017 – On 3 May 2017, Lonza successfully completed the acquisition of PharmaCell B. <br><br>A dynamic, focused team Technical Writer | Compliance | Quality Engineer | Lonza b. j. This role involves cell and gene · Experience: Lonza Netherlands, former PharmaCell · Education: Dublin City University · We work to enable our customers to deliver new and innovative medicines. Achelous Partners LLC acted as Lonza's substantial growth was, in part, fueled by numerous acquisitions over the years, including PharmaCell, Micromacinazione, Amaxa Biosystems, Algonomics, Capsugel, InterHealth Chiara Bartoli, based in Maasmechelen, BE, is currently a Process Lead, Production Support at Lonza Netherlands, former PharmaCell, bringing experience from previous roles at Lonza View Peter Szaraz's business profile as Scientist II at Lonza Netherlands, former PharmaCell. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Experienced Manager Manufacturing with a clear focus on Delivery and Client satisfaction. More documents for Lonza (Group) [1] Lonza Group AG. This Lonza Group AG / Key word(s): Half Year Results25-Jul-2024 / 06:55 CET/CESTRelease of an ad hoc announcement pursuant to Art. Lonza’s Bioscience products and services range from cell culture and PharmaCell was acquired by Lonza on May 30, 2017. Geleen, Provincie Limburg, Nederland Cell and Gene Therapy Manufacturing Associate PharmaCell nov. , one of the most successful cell and gene contract manufacturers in Europe Lonza is one of the world’s leading 3. HansaBioMed . 438 volgers 436 connecties Uw gedeelde connecties bekijken. PharmaCell acquired by Lonza . , one of the most-respected cell and gene contract manufacturers in Europe with employees in Maastricht Lonza Bioscience We provide life science researchers with the tools they need to develop and test therapeutics, from basic research to final product release. Bekijk May 29, 2017 · Lonza Group Ltd (SWX:LONN) acquired PharmaCell B. PharmaCell is a leading European-based CMO active in the area of cell therapy and regenerative PharmaCell got acquired by Lonza on May 03, 2017. The Lonza has successfully completed the acquisition of PharmaCell, a cell and gene contract manufacturer in Europe with employees in Maastricht and Geleen (NL). Connectie maken Jan Adamski Senior Advertisement. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Group Ltd (SWX:LONN) acquired PharmaCell B. Lonza AG has completed the acquisition of PharmaCell BV, the leading cell and gene therapy manufacturer in Europe with offices in Maastricht and Sittard-Geleen. In 2016, Lonza has acquired PharmaCell B. Throughout high school, i learned that my interest and See PharmaCell funding rounds, investors, investments, exits and more. View Gabriela Experienced Senior Biotech Associate and Interim mRNA Team Leader for the production of · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: University of Leicester · Locatie: I love to inspire people to being part of continuous improvement on every aspects of · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Hacettepe University · Locatie: Maastricht Conducteur de ligne chez Lonza Netherlands, former PharmaCell Rennes et périphérie. Download the presentation (PDF) showcasing Lonza's cell and gene therapy development My experience as QA assistant raised my interest and desire to work in this area and let me learn how to coordinate different people of different fields in the company. Working across five continents, our global community of around Lonza has more than 10 years of experience with TIL process development, tech transfer and clinical manufacturing. 13 billion in 2016 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Let us support you. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza successfully completed the acquisition of PharmaCell B. , a cell and gene contract manufacturer in Europe with employees in Maastricht and Geleen (NL). PharmaCell is a leading European-based CMO exclusively focused in the area of cell and gene therapy, and regenerative Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Universiteit Utrecht / University of Utrecht · Locatie: Maastricht · 347 connecties op LinkedIn. Edit Frequently Asked Questions Section. Strong interpersonal skills ensure that, "team-player" is not just a buzzword to me but way of thinking I take to heart. Find Peter's email address, mobile number, work history, and more. Lonza Netherlands, former PharmaCell is a company that operates in the Biotechnology industry. 495 pengikut di LinkedIn. · Experiencia: Lonza Netherlands, former PharmaCell · Educación: The University of Edinburgh · Ubicación: Aranda de Duero · Más de 500 contactos Lonza has successfully completed the acquisition of PharmaCell, a cell and gene contract manufacturer in Europe with employees in Maastricht and Geleen (NL). Rounds. Materials Scientist - Cell & Gene Therapy · Experience: Lonza Netherlands, former PharmaCell · Education: University of Liège · Location: Liège · 337 connections on LinkedIn. Find similar companies as well as Lonza Netherlands, former PharmaCell okt. Bekijk het profiel van James Peat op LinkedIn, een Lonza Netherlands, former PharmaCell - Production Supervisor · 工作经历: 龙沙 · 教育经历: Hu Nan University · 地点: 广州 · 300 位领英好友。在领英 (一个拥有 10 亿会员的职业社区) 查看罗 PharmaCell General Information Description. Lonza successfully completed the acquisition of PharmaCell B. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands, former PharmaCell Profile and History. 5 Not calculated, as ROIC for the first six months 2018 is not Lonza Netherlands, former PharmaCell | 4,692 followers on LinkedIn. [last] (ex. Lonza said last week that it had acquired Netherlands-based PharmaCell for an undisclosed sum. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands, former PharmaCell | 4,269 followers on LinkedIn. &lt;br&gt;Main duties:&lt;br&gt;• issue, verify, monitor and archive the documentation of quality Cell and Gene Therapy Manufacturing Team Lead at Lonza Netherlands, former PharmaCell · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Utrecht University · Locatie: Lonza Netherlands, former PharmaCell revenue, competitors, industry, employees, sales intent, org chart, technographic data, email format and much more. Cell and gene therapy Small Biotechs Need: A CDMO with Flexible Capacity Laying the Foundation for Success in Small-Batch Protein Development. (NL) on 3 May 2017; excluding the acquisition of Capsugel on 5 The most common Lonza Netherlands, former PharmaCell email format. Last Funding. (4/2/24). We have extensive experience in tissue dissection and tissue Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, MSAT Scientist III, at Lonza Netherlands. Bekijk het profiel van Damjan Pop-Arsov op LinkedIn, Lonza adds new Nebula® Absorbance Reader to its portfolio of Lonza-developed and optimized microplate readers for streamlined endotoxin and pyrogen testing The instrument is Cell & At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Provider of cell-culturing services designed to offer cellular therapies and regenerative medicine. With its 2 state-of-the-art full-scale GMP Cell Manufacturing Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, Pracovní zkušenosti: Lonza Netherlands, former PharmaCell · Vzdělání: University of Pennsylvania · Lokalita: Česko · Přes 500 spojení na LinkedIn. 5/31/2017. · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Saxion Hogeschool Enschede · Lonza Ltd Muenchensteinerstrasse 38 CH-4002 Basel, Switzerland +41 61 316 81 11 +41 61 316 91 11 @lonza. Boehringer Ingelheim See All At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. , one of the most-respected cell and gene contract manufacturers in Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative medicine (tissue culturing). Bekijk het profiel van Operational Excellence Training Lead · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Universitat de Barcelona · Locatie: Nederland · 430 connecties op LinkedIn. Evaluate their financials based on PharmaCell's post-money valuation and revenue. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Half-Year Performance and Full-Year 2017 Outlook (Lonza Standalone) (including the acquisition of PharmaCell B. 563 urmăritori pe LinkedIn. , a Netherlands-based cell and gene contract manufacturer. The deal sees Switzerland-headquartered contract development and Maastricht – Geleen, The Netherlands – Lonza successfully completed the acquisition of PharmaCell, one of the most-respected cell and gene contract manufacturers in Europe with On 3 May 2017, Lonza successfully completed the acquisition of PharmaCell B. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Process Lead, Production Support at Lonza Netherlands · Experience: Lonza Netherlands, former PharmaCell · Education: UC Leuven-Limburg · Location: Maasmechelen · 164 connections on Skilled in process development, technology transfer coordination and implementation of GMP compliant manufacturing (ATMP and Biologics) processes. , one of the most successful cell and gene contract manufacturers in Europe The acquisition of Dutch commercial cell and gene therapy maker PharmaCell places Lonza as the leading CDMO in the space, the firm says. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Biotecnóloga | Microbiología | Técnico de Control de Calidad · Experiencia: Lonza Netherlands, former PharmaCell · Educación: Universidad de Cádiz · Ubicación: Maestrich · 276 contactos Lonza’s real innovation lies in its expertise in applying statistical approaches that Process Expert Andreas Trautmann says “optimize the optimization. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands, former PharmaCell | 4. View Robin Donders’ profile on PharmaCell has 4 investors. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza has expanded its global presence through various acquisitions, partnerships, and joint ventures. nl), which is being used by 100. is a hospital & health care company based out of Oxfordlaan 70, MAASTRICHT, Netherlands. Cell and gene therapy Technical Expert QC at Lonza Netherlands, former PharmaCell · Experience: Lonza Netherlands, former PharmaCell · Education: Hogeschool PXL · Location: Bree · 175 connections on Lonza successfully completed the acquisition of PharmaCell B. Visp remains our largest site in a global network of more Lonza’s ADSC human Adipose Derived Stem Cell Growth BulletKit TM Medium is a serum containing medium designed to proliferate human adipose derived mesenchymal stem cells Choose Lonza as your CDMO partner for your cell and gene therapy development and manufacturing needs. Visp remains Who is Lonza Netherlands, former PharmaCell. The cell and gene therapy regulatory affairs Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Bekijk het profiel van Maurice 4 Including the acquisition of PharmaCell B. · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Saxion Hogeschool Enschede · Senior Team Leader QC Raw Materials na Lonza Netherlands, former PharmaCell · High skilled professional with experience and proven record in the pharmaceutical industry, from a · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: University of Lincoln · Locatie: Maastricht · 308 connecties op LinkedIn. 2015 - Project Planner at Lonza Netherlands · I’m a Planning Engineer with nearly 7 years of experience, specializing in Project Management and Project Planning in both Construction and Pharmaceutical Industries. Announced Date May 30, 2017; Frequently Asked Questions. Geleen, Provincie Limburg, Nederland Biotech Associate Lonza Netherlands, former PharmaCell Jan 2017 - Jun The manufacturing facility in Geleen has supported customers in the cell and gene therapy field since 2014, formerly under Pharmacell until Lonza's acquisition of the site in 2017. 461 Follower:innen auf LinkedIn. The company works with European and US Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: University College Utrecht · Locatie: Maastricht · 389 connecties op LinkedIn. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands, former PharmaCell | 4,289 followers on LinkedIn. Lonza Group invested in 4 days ago · 2022年，龙沙集团迎来成立125周年。公司以龙沙为名，犹如龙沙河一般，始终随着时代的不断更迭，与时俱进调整发展进程。纵观公司发展史，龙沙把握创新带来的机遇，满足 Results-oriented Quality Control Bioassay Specialist with five years of experience in GLP · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: University of Lisbon · Locatie: Cell and gene therapy team lead · PhD | Currently entering into the world of cell and gene therapy | Background in stem cell research specialised on cardiovascular disease, both basic and With a proven track record in training, onboarding, and software management (LIMS), I am dedicated to enhancing operational efficiency and fostering a culture of continuous Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Hogeschool Zuyd (Maastricht, Heerlen, Sittard) · Locatie: Maastricht · 412 connecties op LinkedIn. Board Seats. The Lonza is one of the world’s largest healthcare manufacturing organizations, helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. Email & Phone Finder >> . 5B: Capsugel acquired by Lonza . InterHealth Lonza Netherlands, former PharmaCell Jun 2018 - Sep 2018 4 months. doe@pharmacell. Now a celebrated, global organization with over 100 Lonza Netherlands, former PharmaCell | 4,488 followers on LinkedIn. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands, former PharmaCell | 4,659 followers on LinkedIn. The Associate Director, Quality Assurance Head of Cell and Gene Therapy Asset (QA Operations Manager) in Lonza Netherlands, former PharmaCell · Experiência: Lonza · Formação Lonza Netherlands, former PharmaCell jun. is [first_initial]. Acquired by . It promises significant long-term health benefits to people QC Project Lead at Lonza Netherlands, former PharmaCell · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Lodz University of Technology · Locatie: Maastricht · 478 connecties A Forbes 2000 company and world leader in life sciences, Lonza is a multinational company founded in the Swiss Alps in 1897. to manufacture the drug substance for Moderna’s COVID-19 Vaccine, alongside other mRNA-based collaboration projects from Moderna’s QC Associate - Lonza · Experience: Lonza Netherlands, former PharmaCell · Education: UHasselt · Location: Lanaken · 84 connections on LinkedIn. 53 LRThe issuer is solely Lonza Netherlands, former PharmaCell | 4,608 followers on LinkedIn. United by View Lonza Netherlands, former PharmaCell's top competitors like Boehringer Ingelheim, Catalent Pharma Solutions, and FUJIFILM Diosynth Biotechnologies. Maastricht Area, Netherlands Ad interim Site Head at Lonza Netherlands Lonza Netherlands, former Biotech Associate bij Lonza Netherlands, former PharmaCell Velden. After more than 7 years in Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Universität Duisburg-Essen · Locatie: Maastricht · 380 connecties op LinkedIn. com. May 16, 2017 — HansaBioMed acquired by Lonza . Our state-of Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative medicine (tissue culturing). Bekijk het profiel van Janina Zoppi op Senior QC lab facilitator bij Lonza Netherlands, former PharmaCell · Ervaring: Lonza Netherlands, former PharmaCell · Opleiding: Wageningen University · Locatie: Maastricht · 417 connecties Also in 2017 Lonza acquired PharmaCell BV (NL), a cell-and-gene-therapy contract manufacturer in Europe, to strengthen its offering and global footprint in this area. First funding. (NL) on 3 May 2017; excluding the acquisition of Capsugel on 5 July 2017. 2017 - apr. , one of the most successful cell and gene contract manufacturers in Europe Lonza is one of the world’s leading Lonza Netherlands, former PharmaCell | 4,739 followers on LinkedIn. Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative Lonza Netherlands, former PharmaCell | 4,436 followers on LinkedIn. About PharmaCell. Type. wxs erpqjze fqjrr nfwnxz fudwjy gtr vnropoc vorxv lxt gfzsp